Analyst Ratings for Ultragenyx Pharma (RARE)
RARE Rating Summary
RARE Price Target Summary
- Highest: $120.00 (JPMorgan)
- Lowest: $34.00 (Evercore ISI)
- Average: $63.83
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$63.83 (+200.4%)
* Over Last 12-Mos
Rating Score: 8.5 / 10
Percentile Rank: 87%
Avg. $ Target:
$63.83 (+200.4%)
* Over Last 12-Mos
Rating Score: 8.5 / 10
Percentile Rank: 87%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/20/2025 | Wells Fargo » Updated 12/30/2025 |
Ben Burnett | New Coverage | Overweight (N/A) |
45.00 (65.00) |
32.63 (21.25) |
-34.88% | Details |
| 8/25/2025 | Evercore ISI » Updated 2/18/2026 |
Gavin Clark-Gartner | New Coverage | Outperform (N/A) |
34.00 (37.00) |
29.78 (21.25) |
-28.64% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
